During the past decade, Injury Care Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Injury Care Research" #1 sponsor was "Pfizer" with 2 trials, followed by "Regenesis Biomedical, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored and "Axolotl Biologix" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Injury Care Research" #1 collaborator was "Camurus AB" with 1 trials as a collaborator, "Chemo Research" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator and "MCRA" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Injury Care Research" are "Chronic Pain" (2 trials), "Osteoarthritis" (2 trials), "Osteoarthritis, Hip" (2 trials), "Ankle Osteoarthritis" (1 trials) and "Bone Loss" (1 trials). Many other conditions were trialed in "Injury Care Research" in a lesser frequency.

Most popular intervention types in "Injury Care Research" are "Drug" (16 trials), "Biological" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), ""Drug/Placebo: 0.9% Normal Saline"" (1 trials), "AGN-214868" (1 trials), "AGN-214868 Placebo (Vehicle)" (1 trials) and "Amniotic Suspension Allograft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Injury Care Research" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Injury Care Research". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Injury Care Research, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Injury Care Research, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".